| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 8.25e-05 | 5 | 58 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 1.23e-04 | 6 | 58 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 1.23e-04 | 6 | 58 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 2.30e-04 | 8 | 58 | 2 | GO:0005237 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 2.64e-04 | 43 | 58 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | vinculin binding | 6.34e-04 | 13 | 58 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | glycine binding | 7.38e-04 | 14 | 58 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | lamin binding | 1.37e-03 | 19 | 58 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 1.37e-03 | 19 | 58 | 2 | GO:0032794 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.01e-03 | 86 | 58 | 3 | GO:0005254 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 4.52e-05 | 142 | 57 | 5 | GO:0006906 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 4.84e-05 | 144 | 57 | 5 | GO:0090174 | |
| GeneOntologyBiologicalProcess | muscle cell development | 7.85e-05 | 259 | 57 | 6 | GO:0055001 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 9.98e-05 | 531 | 57 | 8 | GO:0042692 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G2/M phase transition | 1.03e-04 | 33 | 57 | 3 | GO:1902751 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.07e-04 | 89 | 57 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | plasma membrane repair | 1.13e-04 | 34 | 57 | 3 | GO:0001778 | |
| GeneOntologyBiologicalProcess | organelle fusion | 1.79e-04 | 190 | 57 | 5 | GO:0048284 | |
| GeneOntologyBiologicalProcess | nucleus localization | 2.45e-04 | 44 | 57 | 3 | GO:0051647 | |
| MousePheno | decreased skeletal muscle fiber diameter | 1.05e-05 | 42 | 46 | 4 | MP:0009402 | |
| Domain | Glycine_rcpt_A | 5.66e-05 | 4 | 58 | 2 | IPR008127 | |
| Domain | Gprotein_alpha_I | 2.62e-04 | 8 | 58 | 2 | IPR001408 | |
| Domain | G-alpha | 1.11e-03 | 16 | 58 | 2 | PF00503 | |
| Domain | GproteinA_insert | 1.11e-03 | 16 | 58 | 2 | IPR011025 | |
| Domain | - | 1.11e-03 | 16 | 58 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 1.11e-03 | 16 | 58 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 1.25e-03 | 17 | 58 | 2 | IPR001019 | |
| Domain | DEP | 2.10e-03 | 22 | 58 | 2 | PF00610 | |
| Domain | DEP | 2.10e-03 | 22 | 58 | 2 | PS50186 | |
| Domain | DEP | 2.10e-03 | 22 | 58 | 2 | SM00049 | |
| Domain | DEP_dom | 2.30e-03 | 23 | 58 | 2 | IPR000591 | |
| Domain | GABAA/Glycine_rcpt | 2.30e-03 | 23 | 58 | 2 | IPR006028 | |
| Domain | C2 | 7.86e-03 | 131 | 58 | 3 | PF00168 | |
| Domain | TPR_repeat | 8.19e-03 | 133 | 58 | 3 | IPR019734 | |
| Domain | Neurotransmitter_ion_chnl_CS | 8.61e-03 | 45 | 58 | 2 | IPR018000 | |
| Domain | C2 | 8.88e-03 | 137 | 58 | 3 | SM00239 | |
| Domain | Neur_chan_memb | 8.99e-03 | 46 | 58 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 9.37e-03 | 47 | 58 | 2 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 9.37e-03 | 47 | 58 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 9.37e-03 | 47 | 58 | 2 | IPR006029 | |
| Domain | - | 9.37e-03 | 47 | 58 | 2 | 2.70.170.10 | |
| Domain | Neur_channel | 9.37e-03 | 47 | 58 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 9.37e-03 | 47 | 58 | 2 | IPR006202 | |
| Domain | C2 | 9.79e-03 | 142 | 58 | 3 | PS50004 | |
| Domain | - | 1.09e-02 | 148 | 58 | 3 | 2.60.40.150 | |
| Domain | TPR-contain_dom | 1.13e-02 | 150 | 58 | 3 | IPR013026 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 8.21e-05 | 5 | 41 | 2 | MM15582 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.66e-04 | 37 | 41 | 3 | M42558 | |
| Pathway | PID_CXCR4_PATHWAY | 1.97e-04 | 100 | 41 | 4 | M124 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.29e-04 | 8 | 41 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.29e-04 | 8 | 41 | 2 | M47643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.93e-04 | 9 | 41 | 2 | M47641 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.03e-04 | 205 | 41 | 5 | M752 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 3.61e-04 | 48 | 41 | 3 | M219 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.35e-04 | 12 | 41 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.35e-04 | 12 | 41 | 2 | M47559 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 6.31e-04 | 13 | 41 | 2 | MM15484 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 7.35e-04 | 14 | 41 | 2 | M27734 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 7.35e-04 | 14 | 41 | 2 | M64 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 7.35e-04 | 14 | 41 | 2 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 7.35e-04 | 14 | 41 | 2 | M750 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 7.89e-04 | 144 | 41 | 4 | MM14501 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 8.80e-04 | 65 | 41 | 3 | M15 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1 | 9.65e-04 | 16 | 41 | 2 | M47457 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.06e-03 | 270 | 41 | 5 | M15514 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.09e-03 | 17 | 41 | 2 | M47544 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.09e-03 | 70 | 41 | 3 | M12294 | |
| Pubmed | NPM1 FRA10AC1 SPAG1 MYH10 HSPH1 ATG4C SPG11 RGS11 GNAI1 CHD6 GNAI3 DMD NEB CCDC191 | 7.63e-08 | 1442 | 58 | 14 | 35575683 | |
| Pubmed | DOCK1 NPM1 SERPINB7 RCHY1 CD80 UBTF ZNF92 GNAI3 NEB ZNF25 SPECC1 SYT13 CLCC1 | 1.62e-07 | 1293 | 58 | 13 | 15342556 | |
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 2.73e-06 | 2 | 58 | 2 | 16420443 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21486794 | ||
| Pubmed | Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site. | 2.73e-06 | 2 | 58 | 2 | 23834509 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 20713446 | ||
| Pubmed | The human genome encodes at least three non-allellic G proteins with alpha i-type subunits. | 2.73e-06 | 2 | 58 | 2 | 2440724 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 33754034 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19959465 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.94e-06 | 536 | 58 | 8 | 15840001 | |
| Pubmed | 3.03e-06 | 538 | 58 | 8 | 10512203 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16962188 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8626678 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20237420 | ||
| Pubmed | FGF13A interacts with NPM1 and UBF and inhibits the invasion of bladder cancer cells. | 8.19e-06 | 3 | 58 | 2 | 37603967 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15788486 | ||
| Pubmed | Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes. | 8.19e-06 | 3 | 58 | 2 | 24595857 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17484771 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 29342363 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8504751 | ||
| Pubmed | Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. | 8.19e-06 | 3 | 58 | 2 | 17154252 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9286703 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30836096 | ||
| Pubmed | Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus. | 8.19e-06 | 3 | 58 | 2 | 29507199 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17920294 | ||
| Pubmed | Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. | 8.19e-06 | 3 | 58 | 2 | 30279732 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 9.15e-06 | 626 | 58 | 8 | 33644029 | |
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 1.25e-05 | 27 | 58 | 3 | 18468998 | |
| Pubmed | 1.62e-05 | 322 | 58 | 6 | 26514267 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 1.64e-05 | 4 | 58 | 2 | 11248120 | |
| Pubmed | Glycinergic input of widefield, displaced amacrine cells of the mouse retina. | 1.64e-05 | 4 | 58 | 2 | 19528249 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9051263 | ||
| Pubmed | Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis. | 1.64e-05 | 4 | 58 | 2 | 37153740 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21486797 | ||
| Pubmed | RGS10 is a selective activator of G alpha i GTPase activity. | 1.64e-05 | 4 | 58 | 2 | 8774883 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 17635935 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11771389 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 20075868 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21289086 | ||
| Pubmed | Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1. | 1.64e-05 | 4 | 58 | 2 | 25825741 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12554758 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11168387 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 35778533 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12379657 | ||
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 1.64e-05 | 4 | 58 | 2 | 28883437 | |
| Pubmed | Guanine nucleotide-binding regulatory proteins in retinal pigment epithelial cells. | 1.64e-05 | 4 | 58 | 2 | 1902575 | |
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 1.64e-05 | 4 | 58 | 2 | 18832081 | |
| Pubmed | Analysis of RGSZ1 protein interaction with Galphai subunits. | 1.64e-05 | 4 | 58 | 2 | 15488169 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10364213 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21931697 | ||
| Pubmed | The cysteine-rich protein family of highly related LIM domain proteins. | 1.64e-05 | 4 | 58 | 2 | 7499425 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 28145731 | ||
| Pubmed | GIV/Girdin activates Gαi and inhibits Gαs via the same motif. | 1.64e-05 | 4 | 58 | 2 | 27621449 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.87e-05 | 497 | 58 | 7 | 36774506 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 12860983 | ||
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 2.72e-05 | 5 | 58 | 2 | 21850450 | |
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 2.72e-05 | 5 | 58 | 2 | 10978845 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 26373672 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 16298104 | ||
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 2.72e-05 | 5 | 58 | 2 | 22706085 | |
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 2.72e-05 | 5 | 58 | 2 | 2820999 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 25242222 | ||
| Pubmed | ABH2 couples regulation of ribosomal DNA transcription with DNA alkylation repair. | 2.72e-05 | 5 | 58 | 2 | 23972994 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 22230296 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 11387333 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 24415754 | ||
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 2.72e-05 | 5 | 58 | 2 | 18721822 | |
| Pubmed | 2.96e-05 | 214 | 58 | 5 | 22199357 | ||
| Pubmed | 3.69e-05 | 1247 | 58 | 10 | 27684187 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 25078664 | ||
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 4.08e-05 | 6 | 58 | 2 | 11196645 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 16371464 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 18434541 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 23236180 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 19401591 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 30975754 | ||
| Pubmed | Cloning and characterization of a novel regulator of G protein signalling in human platelets. | 4.08e-05 | 6 | 58 | 2 | 11955952 | |
| Pubmed | ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2. | 4.08e-05 | 6 | 58 | 2 | 25646266 | |
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 4.08e-05 | 6 | 58 | 2 | 11253162 | |
| Pubmed | Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex. | 5.71e-05 | 7 | 58 | 2 | 22988142 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 15251452 | ||
| Pubmed | Activation state-dependent interaction between Galphai and p67phox. | 5.71e-05 | 7 | 58 | 2 | 16782902 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 12176734 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 8986788 | ||
| Pubmed | 6.33e-05 | 411 | 58 | 6 | 36652389 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 2023909 | ||
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 7.60e-05 | 8 | 58 | 2 | 12509430 | |
| Pubmed | The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. | 7.60e-05 | 8 | 58 | 2 | 15728191 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 16129783 | ||
| Pubmed | Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. | 7.60e-05 | 8 | 58 | 2 | 26126266 | |
| Pubmed | C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. | 7.60e-05 | 8 | 58 | 2 | 15700267 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 7.96e-05 | 1367 | 58 | 10 | 32687490 | |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 9.77e-05 | 9 | 58 | 2 | 38651641 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 25488665 | ||
| Pubmed | Tbx1 regulates extracellular matrix-cell interactions in the second heart field. | 1.22e-04 | 10 | 58 | 2 | 31180501 | |
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 26755700 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 8552586 | ||
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 1.22e-04 | 10 | 58 | 2 | 8521505 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.27e-04 | 153 | 58 | 4 | 26365490 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.28e-04 | 910 | 58 | 8 | 36736316 | |
| Cytoband | 18q21.33 | 1.86e-04 | 16 | 58 | 2 | 18q21.33 | |
| Cytoband | 15q24.2 | 7.59e-04 | 32 | 58 | 2 | 15q24.2 | |
| Cytoband | 1p36.22 | 1.02e-03 | 37 | 58 | 2 | 1p36.22 | |
| Cytoband | 1p31.3 | 1.92e-03 | 51 | 58 | 2 | 1p31.3 | |
| Cytoband | 13q34 | 2.15e-03 | 54 | 58 | 2 | 13q34 | |
| Cytoband | 7q11.21 | 5.00e-03 | 83 | 58 | 2 | 7q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 5.60e-03 | 88 | 58 | 2 | chr13q34 | |
| GeneFamily | Glycine receptors | 4.75e-05 | 5 | 40 | 2 | 868 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 2.91e-06 | 171 | 58 | 5 | 9ecef653f6916572bf5fbee5aea6c577d04e96ba | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.99e-06 | 191 | 58 | 5 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 5.39e-06 | 194 | 58 | 5 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 5.52e-06 | 195 | 58 | 5 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 5.63e-05 | 160 | 58 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 6.05e-05 | 163 | 58 | 4 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.34e-05 | 165 | 58 | 4 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 169 | 58 | 4 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.28e-05 | 171 | 58 | 4 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.62e-05 | 173 | 58 | 4 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.62e-05 | 173 | 58 | 4 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 7.62e-05 | 173 | 58 | 4 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-05 | 175 | 58 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 7.96e-05 | 175 | 58 | 4 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | Healthy-B_memory|Healthy / disease group, cell group and cell class | 9.07e-05 | 181 | 58 | 4 | 7b903076efb90026b9845af0c7a840901451193a | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 9.07e-05 | 181 | 58 | 4 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.07e-05 | 181 | 58 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 9.07e-05 | 181 | 58 | 4 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.47e-05 | 183 | 58 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 9.47e-05 | 183 | 58 | 4 | e3a418b745d7f040adf47be9e1043b945cae47ed | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.47e-05 | 183 | 58 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-05 | 184 | 58 | 4 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 186 | 58 | 4 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.01e-04 | 186 | 58 | 4 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 186 | 58 | 4 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 1.03e-04 | 187 | 58 | 4 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.05e-04 | 188 | 58 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.05e-04 | 188 | 58 | 4 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 188 | 58 | 4 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 188 | 58 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 1.07e-04 | 189 | 58 | 4 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.12e-04 | 191 | 58 | 4 | 67479df0ca4c5a792fd604aded3f75609fec0888 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 191 | 58 | 4 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.12e-04 | 191 | 58 | 4 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 193 | 58 | 4 | 7cc10e8b51091869d46e462f3214999e7b5348b1 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 193 | 58 | 4 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 193 | 58 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 193 | 58 | 4 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 193 | 58 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 194 | 58 | 4 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 194 | 58 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.19e-04 | 194 | 58 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 194 | 58 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 194 | 58 | 4 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 1.21e-04 | 195 | 58 | 4 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2) | 1.21e-04 | 195 | 58 | 4 | e763d9a431052c03cc6d514f2736506c6667e2be | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 195 | 58 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 196 | 58 | 4 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | Leuk-UTI-Myeloid-cDC2|Leuk-UTI / Disease, Lineage and Cell Type | 1.23e-04 | 196 | 58 | 4 | 50465a082f03201936733c55af73bc32e1bdd024 | |
| ToppCell | COVID-19_Mild-cDC|COVID-19_Mild / Disease condition and Cell class | 1.26e-04 | 197 | 58 | 4 | 09045845891de79164124afb6c632e2838906006 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.26e-04 | 197 | 58 | 4 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 197 | 58 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 197 | 58 | 4 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.26e-04 | 197 | 58 | 4 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | COVID-19_Mild-cDC-|COVID-19_Mild / Disease condition and Cell class | 1.26e-04 | 197 | 58 | 4 | 61d6dd023b2ba2bc76f17c06f7c30434ed865171 | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 1.26e-04 | 197 | 58 | 4 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.26e-04 | 197 | 58 | 4 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 1.26e-04 | 197 | 58 | 4 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.28e-04 | 198 | 58 | 4 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B-B_memory|ICU-SEP / Disease, condition lineage and cell class | 1.28e-04 | 198 | 58 | 4 | 4ba2eb32889bbf043f4bbb822e08eb45a2b576ef | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 198 | 58 | 4 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 1.28e-04 | 198 | 58 | 4 | 90f3b227cbc61c268d6d94bc9945a08d83d2d3d5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 1.31e-04 | 199 | 58 | 4 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | cedbc47b1defb5973cf7ab6baaa2d6f2fd481f88 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | 6f7ff0533339fcc9d316f2c77334a79c1409ec4f | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-cDC2|Leuk-UTI / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | 1f1611c590230cd50b9bdca6b58291ab3aab85f2 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.39e-04 | 77 | 58 | 3 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 79 | 58 | 3 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 1.55e-04 | 208 | 58 | 4 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| Computational | Neighborhood of ERCC4 | 7.85e-05 | 321 | 36 | 7 | MORF_ERCC4 | |
| Computational | Neighborhood of PTPRR | 3.57e-04 | 102 | 36 | 4 | MORF_PTPRR | |
| Computational | AcetylCholine receptors. | 9.68e-04 | 14 | 36 | 2 | MODULE_328 | |
| Computational | Neighborhood of CDH4 | 1.05e-03 | 136 | 36 | 4 | MORF_CDH4 | |
| Computational | Neurotransmitter (GABA) receptor. | 1.11e-03 | 15 | 36 | 2 | MODULE_215 | |
| Computational | Genes in the cancer module 267. | 1.11e-03 | 15 | 36 | 2 | MODULE_267 | |
| Drug | iso-THAZ | 3.81e-05 | 4 | 58 | 2 | CID003047783 | |
| Drug | protostrychnine | 3.81e-05 | 4 | 58 | 2 | CID005320746 | |
| Drug | 7-nitroindoline | 3.81e-05 | 4 | 58 | 2 | CID013566747 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 3.81e-05 | 4 | 58 | 2 | CID000383689 | |
| Drug | SC-49648 | 3.81e-05 | 4 | 58 | 2 | CID000195696 | |
| Drug | akuammiline | 3.81e-05 | 4 | 58 | 2 | CID005367018 | |
| Drug | NSC381080 | 3.81e-05 | 4 | 58 | 2 | CID000165497 | |
| Drug | N-methyl-THIP | 3.81e-05 | 4 | 58 | 2 | CID000134373 | |
| Drug | SC-48981 | 3.81e-05 | 4 | 58 | 2 | CID000126573 | |
| Drug | SC-50132 | 3.81e-05 | 4 | 58 | 2 | CID000195719 | |
| Drug | SR 42641 | 3.81e-05 | 4 | 58 | 2 | CID000129049 | |
| Drug | azetidine-3-carboxylic acid | 6.35e-05 | 5 | 58 | 2 | CID000093192 | |
| Drug | Lindane | 6.35e-05 | 5 | 58 | 2 | DB00431 | |
| Drug | Cao C | 6.35e-05 | 5 | 58 | 2 | CID000166617 | |
| Drug | oxanilide | 6.35e-05 | 5 | 58 | 2 | CID000069288 | |
| Drug | iso-THAO | 6.35e-05 | 5 | 58 | 2 | CID000127199 | |
| Drug | ALX1393 | 6.35e-05 | 5 | 58 | 2 | CID016078939 | |
| Drug | pleiocarpamine | 6.35e-05 | 5 | 58 | 2 | CID000558637 | |
| Drug | mafoprazine | 6.35e-05 | 5 | 58 | 2 | CID000071241 | |
| Drug | gevotroline | 6.35e-05 | 5 | 58 | 2 | CID000060546 | |
| Drug | THAZ | 9.50e-05 | 6 | 58 | 2 | CID000171289 | |
| Drug | mV GABA | 9.50e-05 | 6 | 58 | 2 | CID000128435 | |
| Drug | caged glycine | 9.50e-05 | 6 | 58 | 2 | CID000192642 | |
| Drug | brometone | 9.50e-05 | 6 | 58 | 2 | CID000006424 | |
| Drug | minaxolone | 9.50e-05 | 6 | 58 | 2 | CID000071960 | |
| Drug | thiomuscimol | 9.50e-05 | 6 | 58 | 2 | CID000005448 | |
| Drug | thio-THIP | 9.50e-05 | 6 | 58 | 2 | CID000656720 | |
| Drug | AC1L90PQ | 9.50e-05 | 6 | 58 | 2 | CID000436036 | |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HT_HG-U133A | 1.03e-04 | 183 | 58 | 5 | 4455_UP | |
| Drug | alpha-EMTBL | 1.33e-04 | 7 | 58 | 2 | CID000128423 | |
| Drug | CID189778 | 1.33e-04 | 7 | 58 | 2 | CID000189778 | |
| Drug | propyl methanethiosulfonate | 1.33e-04 | 7 | 58 | 2 | CID000529387 | |
| Drug | thiocolchicoside | 1.33e-04 | 7 | 58 | 2 | CID000072067 | |
| Drug | L-serinamide | 1.33e-04 | 7 | 58 | 2 | CID000101138 | |
| Drug | Boc-glycine | 1.33e-04 | 7 | 58 | 2 | CID000078288 | |
| Drug | PK 8165 | 1.33e-04 | 7 | 58 | 2 | CID000071219 | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 5704_UP | |
| Drug | AC1OC6D1 | 1.44e-04 | 104 | 58 | 4 | CID006368594 | |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 7174_UP | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 3865_UP | |
| Drug | WT702 | 1.77e-04 | 8 | 58 | 2 | CID000089643 | |
| Drug | isostrychnine | 1.77e-04 | 8 | 58 | 2 | CID000264626 | |
| Drug | Atonik | 2.27e-04 | 9 | 58 | 2 | CID000069471 | |
| Drug | nortropanol | 2.27e-04 | 9 | 58 | 2 | CID000068147 | |
| Drug | AC1NSJX8 | 2.27e-04 | 9 | 58 | 2 | CID005311059 | |
| Drug | NSC129536 | 2.27e-04 | 9 | 58 | 2 | CID000004815 | |
| Drug | SR 57227A | 2.27e-04 | 9 | 58 | 2 | CID000131746 | |
| Drug | DCQX | 2.27e-04 | 9 | 58 | 2 | CID000001845 | |
| Disease | urinary albumin excretion rate, type 1 diabetes mellitus | 3.41e-06 | 2 | 55 | 2 | EFO_0005667, MONDO_0005147 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 9.48e-05 | 8 | 55 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | Aqueductal Stenosis | 9.48e-05 | 8 | 55 | 2 | C2936786 | |
| Disease | Amnesia | 4.56e-04 | 17 | 55 | 2 | C0002622 | |
| Disease | Tactile Amnesia | 4.56e-04 | 17 | 55 | 2 | C0750906 | |
| Disease | Amnestic State | 4.56e-04 | 17 | 55 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 4.56e-04 | 17 | 55 | 2 | C0236795 | |
| Disease | Global Amnesia | 4.56e-04 | 17 | 55 | 2 | C0262497 | |
| Disease | Hysterical amnesia | 4.56e-04 | 17 | 55 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 4.56e-04 | 17 | 55 | 2 | C0233796 | |
| Disease | longitudinal BMI measurement | 4.89e-04 | 82 | 55 | 3 | EFO_0005937 | |
| Disease | diet measurement, body mass index | 6.34e-04 | 20 | 55 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | insulin measurement | 1.56e-03 | 267 | 55 | 4 | EFO_0004467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLHYCLDYDCQKAEL | 161 | Q7L8C5 | |
| DIEKHKSYHIKDDAY | 626 | Q86V15 | |
| KVEKDYSYLKEICDH | 621 | Q5M775 | |
| LCKAHLEDKYRYLFK | 3206 | P11532 | |
| CVVLKYEKDAFKREH | 116 | P33681 | |
| KCYHFKYEDEDKTLP | 46 | Q96DT6 | |
| KEAAAKYYDAIACLK | 196 | O00170 | |
| CELKADKDYHFKVDN | 21 | P06748 | |
| HDLLKDYDLKYCYVD | 86 | Q9HCJ3 | |
| YEKDCYDRLHKKINH | 141 | O94810 | |
| IHEAGYSEEECKQYK | 56 | P63096 | |
| LLKEEKDLRYCTKHY | 221 | O75311 | |
| VHREARDEYHCKKKY | 581 | Q14739 | |
| KTCKYDKYCADHFKD | 1501 | Q04721 | |
| IHEDGYSEDECKQYK | 56 | P08754 | |
| VEHFCAEFKTKYKLD | 241 | Q92598 | |
| YDKLFKEYCIADLSK | 136 | Q70Z53 | |
| ECYTEEKANKIKADY | 696 | O75037 | |
| QSKYHYKEEAEIICD | 36 | Q8TBE9 | |
| KYEEAISCHKKAAAY | 26 | Q96F24 | |
| HEKDGKAYCRKDYFD | 456 | P49023 | |
| DAKHKYLIALYTKDE | 106 | Q9Y4H2 | |
| EAYIGADIKDKLKCY | 531 | Q13042 | |
| ADIKDKLKCYDFDVH | 536 | Q13042 | |
| EFCYEIKHGDLAKKS | 336 | Q14184 | |
| YKLCDLHKECDNYTE | 1221 | Q14185 | |
| IHDEEIYCKSCYGKK | 51 | Q16527 | |
| ALLVYCVKHYKGDEK | 1136 | Q8TD26 | |
| HLKYDKFDDLCGYLE | 131 | Q8NCU4 | |
| VCDEHKEFKDVKLFY | 101 | Q8TB45 | |
| KADYEKHKVYACEVT | 76 | P01834 | |
| ECAHYFLEVKDKDIK | 296 | Q5TBA9 | |
| DCHKDEKGTIYDYEA | 31 | O75715 | |
| KALDYESCEHYELKV | 326 | P55291 | |
| DEGDEVKFKSYCLKH | 351 | Q92613 | |
| CIIHYAGKVDYKADE | 576 | P35580 | |
| KDYHTLKVYECELEA | 1406 | A0AVI2 | |
| ILKEEKDLRYCTKHY | 216 | P23415 | |
| KKTQYEEHIYRCEDE | 601 | Q96ST3 | |
| FDKLLKHYEAKPDCE | 356 | Q13972 | |
| YYDEAQKIKEKHREE | 386 | O94993 | |
| DEKKENYHKHACREY | 501 | Q86UE8 | |
| YAKAEALCKEYGETK | 281 | Q5VW32 | |
| ECYHKLDSLTYKIDE | 66 | Q96S66 | |
| HKSVLDSFLKYDCKD | 826 | Q96JI7 | |
| KCTEYLDRAEKLKEY | 61 | O75351 | |
| HKKIHTREYSYKCEE | 191 | Q03936 | |
| HDAELEKRKEICKFY | 296 | P61129 | |
| DFKYIEKCSDVKHLE | 26 | Q07617 | |
| DKNYKDALSKYSECL | 636 | Q07617 | |
| KVYGFHKDYIECAEK | 106 | O75635 | |
| HKDYIECAEKLYDAK | 111 | O75635 | |
| DKTYECKECKKIFYH | 171 | P17030 | |
| CEYHGKNYKILEEFK | 116 | B2RUY7 | |
| EHKYIHTGEKLYKCE | 266 | Q03924 | |
| YCDICHLFDKDKKQY | 86 | Q96PM5 | |
| DAYHKKCDQKKKDYE | 341 | P17480 | |
| AKDVDEYKLKDHYLE | 961 | Q9NYI0 | |
| EVKYDDLYHCLVSKD | 4301 | Q5THJ4 | |
| KRIHTREKAYKCDEY | 391 | Q9Y2Q1 | |
| YEAIKKLDQCKDHTY | 726 | P20929 | |
| ASDCKYKEAYEKAKG | 1571 | P20929 | |
| EIASDYKYKLDHEKQ | 4001 | P20929 |